LUNG-ROLL: Treatment Patterns and Cost of Illness of Lung Cancer in Canada - LUNG-ROLL

Study identifier:D133HR00044

ClinicalTrials.gov identifier:NCT07143110

EudraCT identifier:N/A

CTIS identifier:N/A

Will Be Recruiting

Official Title

LUNG-ROLL: Treatment Patterns and Cost of Illness of Lung Cancer in Canada

Medical condition

Lung Neoplasms

Phase

N/A

Healthy volunteers

No

Study drug

-

Sex

All

Estimated Enrollment

60000

Study type

Observational

Age

18 Years - 130 Years

Date

Study Start Date: 20 Aug 2025
Estimated Primary Completion Date: 30 Sept 2027
Estimated Study Completion Date: 30 Sept 2027

Study design

Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Aug 2025 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria